-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Canertinib is a targeted therapy drug used to treat certain types of cancer, specifically those that are characterized by the presence of abnormalities in the Anaplastic Lymphoma Kinase (ALK) gene.
The production process of canertinib involves several steps, from the extraction of the active ingredient to the final product.
- Extraction of the Active Ingredient: Canertinib is extracted from a plant called the Madagascar periwinkle.
This plant is known to contain a variety of alkaloids, which have been found to have medicinal properties. - Purification of the Active Ingredient: Once the active ingredient is extracted, it needs to be purified.
This is done by using various chemical and physical methods to remove any impurities that may be present. - Synthesis of Canertinib: After the active ingredient has been purified, it is then synthesized into canertinib.
This involves a series of chemical reactions that are carried out in a laboratory setting. - Quality Control: Before canertinib can be used as a medication, it must go through a series of quality control tests.
This includes testing for purity, potency, and stability. - Final Product: Once canertinib passes all of the quality control tests, it is then formulated into the final product.
This can include adding excipients, such as fillers and binders, to make the medication more stable and easier to administer. - Packaging and Distribution: Once the final product has been produced, it is then packaged into individual doses or bottles, and distributed to pharmacies and hospitals.
- Monitoring of side effects: Canertinib like all medications have potential side effects, so it is important to monitor patients for any adverse reactions and to report any serious side effects to the relevant authorities.
In conclusion, the production process of canertinib is a multi-step process that requires precision and care.
From the extraction of the active ingredient to the final product, every step must be carried out with care and attention to detail.
Only then can we ensure that the final product is safe and effective for use in treating cancer.